Microsoft to launch $40M AI health initiative

AI has the potential to vastly improve healthcare around the world, but existing barriers and lack of resources could be stunting deployment of the technology and its future solutions. That’s why Microsoft is launching a $40 million, five-year program that aims to leverage the company’s existing initiative and AI technology to help researchers and organizations tackle health challenges.

Microsoft aims to ensure nonprofits, academia and research organizations have access to AI to improve research, health insights and access to care.

The new program, called AI for Health, is part of Microsoft’s AI for Good initiative, which is a $165 million commitment to organizations and people working to address societal issues. AI for Health will focus on three areas: quest for discovery, global health insights, and health equity.

"Artificial intelligence has the potential to solve some of humanity's greatest challenges, like improving the health of communities around the world," Microsoft president Brad Smith said in a statement. "We know that putting this powerful technology into the hands of experts tackling this problem can accelerate new solutions and improve access for underserved populations.”

Currently, less than 5% of the world’s AI professionals work in health and nonprofit organizations, and the barrier for many health researchers to deploy AI and data science can be high without necessary talent and resources.

So far, Microsoft announced a handful of grantees through AI for Health:

  • BRAC
  • Fred Hutchinson Cancer Research Center
  • Intelligent Retinal Imaging Systems
  • Novartis Foundation
  • PATH
  • Seattle Children’s Research Institute

The AI for Health program will build on Microsoft’s existing collaborations , which are already tackling issues like Sudden Infant Death Syndrome (SIDS), leprosy, diabetic retinopathy and biomedical data sharing.

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.